South Africa: Vaccine Rollout - Here Is Where South Africa Stands allafrica.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from allafrica.com Daily Mail and Mail on Sunday newspapers.
Vaccine rollout: Here is where South Africa stands
GroundUp21 December 2020
Subscribe
Only a massive global rollout of an effective vaccine can end the Covid-19 pandemic in the short term. The vaccine is being rolled out in the United Kingdom and United States. It’s expected to become available in Europe imminently.
This is where things stand in South Africa.
The Department of Health is playing its cards very close to its chest. The department has been extremely reluctant to provide any details of how a vaccination plan would work.
In response to our questions, spokesperson Popo Maja said that the department is not commenting on any vaccine related to Covid-19, and that “the minister will pronounce on this at an appropriate time”.
New alliance seeks to fight ‘plague’ of fake medicines
The COVID-19 pandemic triggered a surge in fake medical products released in markets across the world. Copyright: Image by Steve Buissinne from Pixabay. This image has been cropped.
Speed read
COVID-19 has resulted in a surge in falsified medical products
Collaboration and transparent reporting needed to tackle scourge, experts say
Share this article:
Republish
We encourage you to republish this article online and in print, it’s free under our creative commons attribution license, but please follow some simple guidelines:
You have to credit our authors.
You have to credit SciDev.Net where possible include our logo with a link back to the original article.
COVAX Announces additional deals to access promising COVID-19 vaccine candidates; plans global rollout starting Q1 2021 miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
COVAX Announces additional deals to access promising COVID-19 vaccine candidates; plans global rollout starting Q1 2021
COVAX Announces additional deals to access promising COVID-19 vaccine candidates; plans global rollout starting Q1 2021 18 December 2020 Reading time:
COVAX now has agreements in place to access nearly two billion doses of several promising vaccine candidates, and laid the groundwork for further doses to be secured through contributions from donors
These agreements mean that all COVAX’s 190 participating and eligible economies will be able to access doses to protect vulnerable groups in the first half of 2021. At least 1.3 billion donor-funded doses will be made available to 92 economies eligible for the Gavi COVAX AMC, targeting up to 20% population coverage by the end of the year.